BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30863947)

  • 1. Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.
    Miceli A; Dueñas-Diez JL
    Int Urogynecol J; 2019 Dec; 30(12):2161-2169. PubMed ID: 30863947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
    Dueñas JL; Miceli A
    Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of ring pessary with support for advanced pelvic organ prolapse.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study.
    Miceli A; Fernández-Sánchez M; Dueñas-Díez JL
    Int Urogynecol J; 2021 Jun; 32(6):1471-1478. PubMed ID: 33620536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Prolapse and Urinary Symptoms After Successful Fitting of a Ring Pessary With Support in Women With Advanced Pelvic Organ Prolapse: A Prospective Study.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Urology; 2016 Jan; 87():70-5. PubMed ID: 26375847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
    Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
    J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Aug; 24(8):954-958. PubMed ID: 28419067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
    Ding J; Song XC; Deng M; Zhu L
    Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?
    Bodner-Adler B; Bodner K; Stinglmeier A; Kimberger O; Halpern K; Koelbl H; Umek W
    Arch Gynecol Obstet; 2019 Mar; 299(3):773-777. PubMed ID: 30656443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
    Nemeth Z; Farkas N; Farkas B
    Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
    Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
    Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
    Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
    Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
    Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
    Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
    Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvaginal management of severe pelvic organ prolapse in nulliparous women.
    Lo TS; Jaili S; Uy-Patrimonio MC; Karim NB; Ibrahim R
    J Obstet Gynaecol Res; 2017 Mar; 43(3):543-550. PubMed ID: 28160508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?
    Miceli A; Fernández-Sánchez M; Polo-Padillo J; Dueñas-Díez JL
    Int Urogynecol J; 2020 Dec; 31(12):2521-2528. PubMed ID: 32062679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.